Physician profile
Alan Rappleye
NPI 1568431575
$14,131.59
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,457 · 2020: $383 · 2021: $492 · 2022: $200 · 2023: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,889.89 | 2019-2023 | Da Vinci Sp |
| Pfizer INC. | $1,851.09 | 2019 | |
| Abbvie INC. | $347.87 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $161.26 | 2019-2021 | |
| Organon LLC | $116.28 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.77 | 2019-2021 | |
| Evofem Biosciences, INC. | $100.72 | 2020-2021 | |
| Therapeuticsmd, INC. | $94.88 | 2020-2021 | |
| Coloplast Corp | $68.50 | 2022 | |
| Myovant Sciences INC. | $64.89 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.61 | 2019-2020 | |
| Lupin INC. | $49.26 | 2019-2020 | |
| Exeltis, USA INC. | $42.13 | 2020-2021 | |
| Allergan, INC. | $38.06 | 2019-2020 | |
| Scynexis, INC. | $32.91 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $26.65 | 2021-2022 | |
| Becton, Dickinson and Company | $19.93 | 2021 | |
| Mayne Pharma Commercial LLC | $19.04 | 2021 | |
| Astellas Pharma US INC | $17.92 | 2019 | |
| Roche Diagnostics Corporation | $15.91 | 2021 | |
| Agile Therapeutics, INC. | $15.02 | 2021 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Rappleye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.